Immune responses following one and two doses of the reformulated, bivalent, killed, whole-cell, oral cholera vaccine among adults and children in Kolkata, India: A randomized, placebo-controlled trial

This publication has 8 references indexed in Scilit:

• A Randomized, Placebo-Controlled Trial of the Bivalent Killed, Whole-Cell, Oral Cholera Vaccine in Adults and Children in a Cholera Endemic Area in Kolkata, India
  PLOS ONE, 2008
• Safety and immunogenicity of a reformulated Vietnamese bivalent killed, whole-cell, oral cholera vaccine in adults
  Vaccine, 2007
• Reduction in Capsular Content and Enhanced Bacterial Susceptibility to Serum Killing of Vibrio cholerae O139 Associated with the 2002 Cholera Epidemic in Bangladesh
  Infection and Immunity, 2005
• Intestinal and Systemic Immune Responses to an Oral Cholera Toxoid B Subunit Whole-Cell Vaccine Administered during Zinc Supplementation
  Infection and Immunity, 2003
• Supplementation with Zinc, but Not Vitamin A, Improves Seroconversion to Vibriocidal Antibody in Children Given an Oral Cholera Vaccine
  The Journal of Infectious Diseases, 2003
• Safety, immunogenicity, and lot stability of the whole cell/recombinant B subunit (WC/rCTB) cholera vaccine in Peruvian adults and children.
  The American Journal of Tropical Medicine and Hygiene, 1999
• Cholera Vaccine in Refugee Settings
  Published by American Medical Association (AMA) ,1998
• Treatment and Vaccination Strategies to Control Cholera in Sub-Saharan Refugee Settings
  JAMA, 1998